Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Repligen Corporation
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.

Number of employees : 1 128 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Filtration119.5344.2%174.9047.8% +46.31%
Proteins65.1224.1%80.7322% +23.97%
Chromatography64.6423.9%73.5520.1% +13.79%
Process Analytics16.416.1%33.359.1% +103.27%
Other Product4.401.6%3.611% -17.91%
Royalty and Other0.1480.1%0.1240% -16.22%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
North America137.8351%175.8148% +27.56%
Europe99.9937%139.1838% +39.19%
APAC32.4312%51.2814% +58.12%
Managers
NameAgeSinceTitle
Tony Hunt562015President, Chief Executive Officer & Director
Jon Snodgres54-Chief Financial Officer
Ralf Kuriyel612016Senior Vice President-Research & Development
Jim Bylund572020Senior Vice President-Global Operations & IT
Squire Servance--Secretary, Chief Compliance Officer & Senior VP
Thomas F. Ryan782003Independent Director
Karen Dawes682012Chairman
Nicolas M. Barthelemy542014Independent Director
Glenn P. Muir612015Independent Director
Rohin Mhatre, Dr.552020Independent Director
Members of the board
NameAgeSinceTitle
Karen Dawes682012Chairman
Thomas F. Ryan782003Independent Director
Tony Hunt562015President, Chief Executive Officer & Director
Nicolas M. Barthelemy542014Independent Director
Glenn P. Muir612015Independent Director
Rohin Mhatre, Dr.552020Independent Director
Carrie Eglinton Manner462020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,904,466 50,984,197 92.9% 0 0.0% 92.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 4,329,307 7.90%
Roy T. Eddleman 3,500,000 6.39%
Invesco Advisers, Inc. 1,928,206 3.52%
BVF Partners LP 1,810,535 3.31%
BlackRock Fund Advisors 1,625,636 2.97%
Marshall Wace LLP 1,481,280 2.70%
Fred Alger Management LLC 1,310,814 2.39%
Winslow Management Co. LLC 1,248,800 2.28%
Select Equity Group LP 1,238,484 2.26%
T. Rowe Price Associates, Inc. (Investment Management) 1,188,465 2.17%
Company contact information
Repligen Corp.
41 Seyon Street
Building 1
Suite 100
Waltham, MA 02453

Phone : +1.781.250.0111
Fax : +1.781.250.0115
Web : http://www.repligen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Repligen Corporation